{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:07:45Z","timestamp":1778818065766,"version":"3.51.4"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"none"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>Atrial fibrillation (AF) and renal failure coexist and interact. However, scarce data about association between renal function and clinical outcomes in patients undergoing catheter ablation for AF are available. We sought to evaluate long-term renal function and clinical outcomes after AF ablation.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>We enrolled 791 non-dialysis patients undergoing catheter ablation for AF, and evaluated the incidence of worsening renal function (WRF) after the procedure, defined as &gt;30% decline in estimate glomerular filtration rate.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>Mean follow-up duration was 5.1\u00b12.5 years. Five hundreds and twenty-six patients (66.5%) were free from recurrent atrial arrhythmias without any antiarrhythmic drugs at the time of final follow-up. Cumulative incidence of WRF was 13.2% at 5-year after procedure, which was significantly higher in patients with recurrent AF compared to those without (21.6% versus 8.7%, P&lt;0.001). In the multivariable analysis, recurrent AF was an independent risk factor for WRF (adjusted hazard ratio [HR] 1.89, 95% confidence interval 1.27\u20132.81, P = 0.002), along with congestive heart failure, diabetes, and eGFR &lt;60 ml\/min\/1.73m<jats:sup>2<\/jats:sup>at baseline. Patients with WRF had significantly higher 5-year incidences of all-cause death, cardiovascular death, heart failure hospitalization, ischemic stroke, and major bleeding compared to those without WRF. After adjustment of baseline differences in the multivariate Cox model, the excessive risks of WRF for all-cause death and heart failure hospitalization remained significant (adjusted HR 3.46, P = 0.002; adjusted HR 3.67, P&lt;0.001).<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusions<\/jats:title><jats:p>In AF patients undergoing catheter ablation for AF, arrhythmia recurrence was associated with WRF during follow-up, which was a strong predictor of adverse clinical outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0241449","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T18:43:09Z","timestamp":1604947389000},"page":"e0241449","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Renal function and outcomes in atrial fibrillation patients after catheter ablation"],"prefix":"10.1371","volume":"15","author":[{"given":"Tetsuma","family":"Kawaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4587-9031","authenticated-orcid":true,"given":"Satoshi","family":"Shizuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Takeji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8082-2036","authenticated-orcid":true,"given":"Yusuke","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3515-5526","authenticated-orcid":true,"given":"Masashi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Yokomatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"key":"pone.0241449.ref001","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archinte.167.11.1130","article-title":"Cardiovascular disease and subsequent kidney disease","volume":"167","author":"EF Elsayed","year":"2007","journal-title":"Arch Intern Med"},{"key":"pone.0241449.ref002","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.amjcard.2010.08.049","article-title":"A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the atherosclerosis risk in communities [aric] study)","volume":"107","author":"AM Chamberlain","year":"2011","journal-title":"Am J Cardiol"},{"key":"pone.0241449.ref003","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amjcard.2014.10.041","article-title":"Anemia and reduced kidney function as risk factors for new onset of atrial fibrillation (from the ibaraki prefectural health study)","volume":"115","author":"D Xu","year":"2015","journal-title":"Am J Cardiol"},{"key":"pone.0241449.ref004","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ahj.2009.06.031","article-title":"Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The niigata preventive medicine study","volume":"158","author":"H Watanabe","year":"2009","journal-title":"Am Heart J"},{"key":"pone.0241449.ref005","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1161\/CIRCULATIONAHA.111.047266","article-title":"Renal function after catheter ablation of atrial fibrillation","volume":"124","author":"Y Takahashi","year":"2011","journal-title":"Circulation"},{"key":"pone.0241449.ref006","doi-asserted-by":"crossref","first-page":"e013204","DOI":"10.1161\/JAHA.119.013204","article-title":"Five-year change in the renal function after catheter ablation of atrial fibrillation","volume":"8","author":"JW Park","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"pone.0241449.ref007","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/heartjnl-2014-306013","article-title":"Changes in renal function after catheter ablation of atrial fibrillation are associated with chads2 and cha2ds2-vasc scores and arrhythmia recurrences","volume":"101","author":"J Kornej","year":"2015","journal-title":"Heart"},{"key":"pone.0241449.ref008","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijcard.2017.09.023","article-title":"Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience","volume":"249","author":"T Kawaji","year":"2017","journal-title":"Int J Cardiol"},{"key":"pone.0241449.ref009","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated gfr from serum creatinine in japan","volume":"53","author":"S Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"pone.0241449.ref010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","article-title":"Gfr decline as an end point for clinical trials in ckd: A scientific workshop sponsored by the national kidney foundation and the us food and drug administration","volume":"64","author":"AS Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"pone.0241449.ref011","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/j.jacc.2017.09.1087","article-title":"Renal outcomes in anticoagulated patients with atrial fibrillation","volume":"70","author":"X Yao","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"pone.0241449.ref012","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"S Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"pone.0241449.ref013","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/biostatistics\/kxy069","article-title":"Subdistribution hazard models for competing risks in discrete time","volume":"21","author":"M Berger","year":"2020","journal-title":"Biostatistics"},{"key":"pone.0241449.ref014","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"PC Austin","year":"2016","journal-title":"Circulation"},{"key":"pone.0241449.ref015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ki.2011.44","article-title":"Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate","volume":"80","author":"SV Brodsky","year":"2011","journal-title":"Kidney Int"},{"key":"pone.0241449.ref016","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix gla protein","volume":"386","author":"G Luo","year":"1997","journal-title":"Nature"},{"key":"pone.0241449.ref017","doi-asserted-by":"crossref","first-page":"e43229","DOI":"10.1371\/journal.pone.0043229","article-title":"Vitamin k-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype","volume":"7","author":"LJ Schurgers","year":"2012","journal-title":"PloS one"},{"key":"pone.0241449.ref018","doi-asserted-by":"crossref","first-page":"c142","DOI":"10.1159\/000312877","article-title":"Warfarin therapy that results in an international normalization ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease","volume":"115","author":"SV Brodsky","year":"2010","journal-title":"Nephron. Clin Pract"},{"key":"pone.0241449.ref019","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2015.03.017","article-title":"Outcomes Registry for Better Informed Treatment of Atrial Fibrillation I. Patients' time in therapeutic range on warfarin among us patients with atrial fibrillation: Results from orbit-af registry","volume":"170","author":"SD Pokorney","year":"2015","journal-title":"Am Heart J"},{"key":"pone.0241449.ref020","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2013-08-523936","article-title":"Differential contribution of fxa and thrombin to vascular inflammation in a mouse model of sickle cell disease","volume":"123","author":"EM Sparkenbaugh","year":"2014","journal-title":"Blood"},{"key":"pone.0241449.ref021","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/jpet.112.194837","article-title":"The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein e-deficient mice","volume":"343","author":"IO Lee","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"pone.0241449.ref022","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2015.03.577","article-title":"Changes in renal function in patients with atrial fibrillation: An analysis from the re-ly trial","volume":"65","author":"M Bohm","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"pone.0241449.ref023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.116.021890","article-title":"Committee RAS, Investigators. On-treatment outcomes in patients with worsening renal function with rivaroxaban compared with warfarin: Insights from rocket af","volume":"134","author":"CB Fordyce","year":"2016","journal-title":"Circulation"},{"key":"pone.0241449.ref024","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.amjcard.2015.01.019","article-title":"Interaction between worsening renal function and persistent congestion in acute decompensated heart failure","volume":"115","author":"M Wattad","year":"2015","journal-title":"Am J Cardiol"},{"key":"pone.0241449.ref025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijcard.2018.04.090","article-title":"Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A uk national study","volume":"267","author":"CA Lawson","year":"2018","journal-title":"Int J Cardiol"},{"key":"pone.0241449.ref026","doi-asserted-by":"crossref","first-page":"e191994","DOI":"10.1001\/jamanetworkopen.2019.1994","article-title":"Safety and efficacy of minimally interrupted dabigatran vs uninterrupted warfarin therapy in adults undergoing atrial fibrillation catheter ablation","volume":"2","author":"A Nogami","year":"2019","journal-title":"JAMA Network Open"},{"key":"pone.0241449.ref027","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.hrthm.2012.06.039","article-title":"Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation\u2014the potential role beyond the cha(2)ds(2)-vasc score","volume":"9","author":"TF Chao","year":"2012","journal-title":"Heart rhythm"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0241449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T11:11:16Z","timestamp":1669547476000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0241449"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0241449","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]}}}